Prevalence and risk factors for skeletal muscle mass loss in individuals with type 1 diabetes.

IF 1.3 Q4 ENDOCRINOLOGY & METABOLISM

Diabetology International Pub Date : 2024-10-30 eCollection Date: 2025-01-01 DOI:10.1007/s13340-024-00770-1

Kanako Shimura, Junnosuke Miura, Zhuo Shen, Takuya Asanuma, Satoshi Takagi, Sari Hoshina, Hiroko Takaike, Yasuko Uchigata, Tetsuya Babazono

{"title":"Prevalence and risk factors for skeletal muscle mass loss in individuals with type 1 diabetes.","authors":"Kanako Shimura, Junnosuke Miura, Zhuo Shen, Takuya Asanuma, Satoshi Takagi, Sari Hoshina, Hiroko Takaike, Yasuko Uchigata, Tetsuya Babazono","doi":"10.1007/s13340-024-00770-1","DOIUrl":null,"url":null,"abstract":"<p><p>This study aimed to the investigate prevalence and factors associated with reduced skeletal muscle mass in non-elderly adults with type 1 diabetes (T1D). Ninety-nine patients (65 women, mean age: 43 ± 11 years, range 20-65 years) with acute-onset T1D who underwent body component analysis between October 2016 and April 2018 were studied. Bioelectrical impedance analysis was used to calculate the skeletal muscle mass index (SMI) of the limbs. A multivariate logistic regression analysis was employed to identify factors related to SMI reduction. Seventeen participants (17.1%) exhibited decreased SMI. There were no significant differences in sex, age, or HbA1c between the low and normal SMI groups. The prevalence of diabetic retinopathy was 58.8% in the low SMI group, which was significantly higher than that in the normal SMI group (15.9%; p < 0.05). The duration of T1D was significantly longer in the low SMI group (25.6 ± 11.3 years) than that in the normal SMI group (20.0 ± 10.0 years, p < 0.04). Multivariate logistic regression analysis revealed that retinopathy, male sex, and body mass index were independent risk factors for low SMI (all p < 0.05). Thus, the factors associated with decreased skeletal muscle mass in non-elderly adult patients with T1D were identified.</p>","PeriodicalId":11340,"journal":{"name":"Diabetology International","volume":"16 1","pages":"92-99"},"PeriodicalIF":1.3000,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11769926/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetology International","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s13340-024-00770-1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}

引用次数: 0

Abstract

This study aimed to the investigate prevalence and factors associated with reduced skeletal muscle mass in non-elderly adults with type 1 diabetes (T1D). Ninety-nine patients (65 women, mean age: 43 ± 11 years, range 20-65 years) with acute-onset T1D who underwent body component analysis between October 2016 and April 2018 were studied. Bioelectrical impedance analysis was used to calculate the skeletal muscle mass index (SMI) of the limbs. A multivariate logistic regression analysis was employed to identify factors related to SMI reduction. Seventeen participants (17.1%) exhibited decreased SMI. There were no significant differences in sex, age, or HbA1c between the low and normal SMI groups. The prevalence of diabetic retinopathy was 58.8% in the low SMI group, which was significantly higher than that in the normal SMI group (15.9%; p < 0.05). The duration of T1D was significantly longer in the low SMI group (25.6 ± 11.3 years) than that in the normal SMI group (20.0 ± 10.0 years, p < 0.04). Multivariate logistic regression analysis revealed that retinopathy, male sex, and body mass index were independent risk factors for low SMI (all p < 0.05). Thus, the factors associated with decreased skeletal muscle mass in non-elderly adult patients with T1D were identified.

查看原文本刊更多论文

求助全文

约1分钟内获得全文求助全文

来源期刊

Diabetology International ENDOCRINOLOGY & METABOLISM-

CiteScore

3.90

自引率

4.50%

发文量

期刊介绍： Diabetology International, the official journal of the Japan Diabetes Society, publishes original research articles about experimental research and clinical studies in diabetes and related areas. The journal also presents editorials, reviews, commentaries, reports of expert committees, and case reports on any aspect of diabetes. Diabetology International welcomes submissions from researchers, clinicians, and health professionals throughout the world who are interested in research, treatment, and care of patients with diabetes. All manuscripts are peer-reviewed to assure that high-quality information in the field of diabetes is made available to readers. Manuscripts are reviewed with due respect for the author''s confidentiality. At the same time, reviewers also have rights to confidentiality, which are respected by the editors. The journal follows a single-blind review procedure, where the reviewers are aware of the names and affiliations of the authors, but the reviewer reports provided to authors are anonymous. Single-blind peer review is the traditional model of peer review that many reviewers are comfortable with, and it facilitates a dispassionate critique of a manuscript.